We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-12.35%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.3B
AUM Growth
-$444M
(-3%)
Cap. Flow
+$1.68B
Cap. Flow
% of AUM
11.73%
Top 10 Holdings %
Top 10 Hldgs %
21.62%
Holding
1,821
New
56
Increased
555
Reduced
957
Closed
250
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$101M |
| 2 |
Amazon
AMZN
|
+$99.5M |
| 3 |
Microsoft
MSFT
|
+$95.8M |
| 4 |
Linde
LIN
|
+$84.2M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$40.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$77.4M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$35.2M |
| 3 |
McCormick & Company Non-Voting
MKC
|
+$14.7M |
| 4 |
CA
CA, Inc.
CA
|
+$13.2M |
| 5 |
Clorox
CLX
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 13.08% |
| 3 | Financials | 12.21% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Consumer Staples | 10.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
GameStop
GME
$9.5B
| $172K | ﹤0.01% |
54,668
-5,748
| -10% | -$20.1K |
|
1402
Brookdale Senior Living
BKD
$3.62B
| $171K | ﹤0.01% |
25,488
-4,307
| -14% | -$36.1K |
|
1403
ProQR Therapeutics
PRQR
$243M
| $171K | ﹤0.01% |
+10,820
| New | +$199K |
|
1404
Rigel Pharmaceuticals
RIGL
$680M
| $171K | ﹤0.01% |
7,417
-1,424
| -16% | -$40.2K |
|
|
ELOX
1405
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $171K | ﹤0.01% |
+357
| New | +$197K |
|
|
SEMG
1406
DELISTED
SEMGROUP CORPORATION
SEMG
| $171K | ﹤0.01% |
12,432
-486
| -4% | -$8.74K |
|
|
PGNX
1407
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $168K | ﹤0.01% |
39,919
-6,959
| -15% | -$35.4K |
|
|
DCH
1408
Dauch Corp
DCH
$1.3B
| $166K | ﹤0.01% |
14,987
-1,588
| -10% | -$21.2K |
|
|
RWT
1409
Redwood Trust
RWT
$616M
| $166K | ﹤0.01% |
10,990
-1,161
| -10% | -$18.7K |
|
1410
Inovio Pharmaceuticals
INO
$79.8M
| $164K | ﹤0.01% |
3,421
-534
| -14% | -$32.4K |
|
1411
First Commonwealth Financial
FCF
$2.12B
| $161K | ﹤0.01% |
13,295
-1,457
| -10% | -$20K |
|
1412
Snap
SNAP
$7.32B
| $161K | ﹤0.01% |
29,251
-13,247
| -31% | -$86.2K |
|
|
APRN
1413
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $161K | ﹤0.01% |
876
+152
| +21% | +$32.3K |
|
|
AVYA
1414
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $161K | ﹤0.01% |
11,026
-1,786
| -14% | -$30.3K |
|
|
NUAN
1415
DELISTED
Nuance Communications, Inc.
NUAN
| $161K | ﹤0.01% |
14,077
-6,639
| -32% | -$93K |
|
1416
Akebia Therapeutics
AKBA
$327M
| $157K | ﹤0.01% |
28,349
-1,079
| -4% | -$8.44K |
|
1417
Cytokinetics
CYTK
$11B
| $157K | ﹤0.01% |
24,919
-4,362
| -15% | -$32K |
|
1418
Knowles
KN
$3.22B
| $156K | ﹤0.01% |
11,748
-1,220
| -9% | -$17.9K |
|
1419
Kite Realty
KRG
$5.95B
| $156K | ﹤0.01% |
11,070
-1,169
| -10% | -$18.4K |
|
1420
Amneal Pharmaceuticals
AMRX
$5.72B
| $155K | ﹤0.01% |
11,477
-1,790
| -13% | -$32.3K |
|
|
SLCA
1421
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $155K | ﹤0.01% |
15,257
-106
| -0.7% | -$1.55K |
|
|
SUM
1422
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $153K | ﹤0.01% |
12,517
-2,051
| -14% | -$28.4K |
|
|
TIVO
1423
DELISTED
Tivo Inc
TIVO
| $152K | ﹤0.01% |
16,206
-1,697
| -9% | -$18.3K |
|
|
SRCI
1424
DELISTED
SRC Energy Inc
SRCI
| $152K | ﹤0.01% |
32,249
-3,481
| -10% | -$23.3K |
|
1425
3D Systems Corp
DDD
$420M
| $150K | ﹤0.01% |
14,711
-1,529
| -9% | -$21K |
|
Similar funds
ProShare Advisors's Q4 2018 Portfolio in Review
As of Q4 2018, ProShare Advisors held 1,821 positions worth $14.3B, down 3% from $14.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
ProShare Advisors deployed $1.68B of net new capital in Q4 2018, opening 56 new positions and adding to 555 existing holdings. Its largest new stake was Linde: 532,831 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was McCormick & Company Non-Voting, an estimated $14.7M trimmed.
- ProShare Advisors's largest Q4 2018 buy was Linde: 532,831 shares worth $83.1M.
- ProShare Advisors added most to Apple in Q4 2018, an estimated $101M increase.
- ProShare Advisors's biggest Q4 2018 reduction was McCormick & Company Non-Voting, cutting an estimated $14.7M.
- ProShare Advisors fully exited Praxair Inc in Q4 2018, selling an estimated $77.4M.
- ProShare Advisors's ten largest holdings make up 22% of its $14.3B portfolio in Q4 2018.
- ProShare Advisors opened 56 new positions and closed 250 in Q4 2018.
- ProShare Advisors's portfolio value fell 3% quarter-over-quarter to $14.3B.
Based on ProShare Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.